Ticker Details
RenovoRx, Inc.
IPO Date:	August 26, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$39.75M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.11 | 4.71%
Avg Daily Range (30 D):	$0.03 | 3.05%
Avg Daily Range (90 D):	$0.03 | 3.43%

Institutional Daily Volume
Avg Daily Volume:	.35M
Avg Daily Volume (30 D):	.29M
Avg Daily Volume (90 D):	.3M

Trade Size
Avg Trade Size (Sh.):	219
Avg Trade Size (Sh.) (30 D):	454
Avg Trade Size (Sh.) (90 D):	446

Institutional Trades
Total Institutional Trades:	8
Avg Institutional Trade:	$1.13M
Avg Institutional Trade (30 D):	$M
Avg Institutional Trade (90 D):	$M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	K

News

Apr 1, 2026 @ 6:20 PM RenovoRx Named to Fast Company’s Annual Lis... Source: Renovorx, Inc.

Jun 26, 2024 @ 12:30 PM University of Nebraska Medical Center Launches Pat... Source: RenovoRx, Inc.

Jun 10, 2024 @ 12:30 PM RenovoRx Appoints Ryan Witt as Senior Vice Preside... Source: RenovoRx, Inc.

Jan 2, 2024 @ 6:35 PM Why Longboard Pharmaceuticals Shares Are Trading H... Source: Avi Kapoor

Dec 28, 2023 @ 6:07 PM Why DouYu International Shares Are Trading Higher ... Source: Avi Kapoor

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.33	$-.09	$-.08
Diluted EPS	$-.33	$-.09	$-.08
Revenue	$1.58M	$.56M	$.54M
Gross Profit	$1.17M	$.48M
Net Income / Loss	$-12.27M	$-3.52M	$-2.94M
Operating Income / Loss	$-12.87M	$-3.47M	$-3.52M
Cost of Revenue	$.32M	$.08M
Net Cash Flow	$-7.56M	$M	$-.13M
PE Ratio